Naloxone hydrocloride intranasal spray - Kindeva Drug Delivery
Alternative Names: Naloxone hydrochloride-intranasal spray - Kindeva Drug Delivery; REZENOPYLatest Information Update: 03 May 2024
At a glance
- Originator Summit Biosciences
- Developer Kindeva Drug Delivery
- Class Antidotes; Behavioural disorder therapies; Benzofurans; Drug withdrawal therapies; Isoquinolines; Ketones; Laxatives; Morphinans; Small molecules
- Mechanism of Action Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Opioid-related disorders